[ORGANIZATION]
Kymera Therapeutics
Featured in 2 tracked stories · first seen
Situations
Global corporate financial performance and sector trends
2 clusters · 30 sources · last updated
Latest: AI infrastructure faces potential $3.5 trillion write-down risk by 2030
Global corporate financial reports show varied performance across several sectors. Evotec SE released preliminary nine-month results for 2026 that exceeded market expectations, reaching approximately 465 million euros, t
Also covered in
-
Kymera Therapeutics and Kion Group see shifts in trading volume and analyst ratings
[BUSINESS] · 2 sources ·